Howard Hughes (HHH) Competitors $67.67 -1.06 (-1.54%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$68.57 +0.90 (+1.32%) As of 08/1/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HHH vs. TSHA, ZG, HLI, WPC, AMH, GLPI, DOC, REG, JEF, and HSTShould you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Taysha Gene Therapies (TSHA), Zillow Group (ZG), Houlihan Lokey (HLI), W.P. Carey (WPC), American Homes 4 Rent (AMH), Gaming and Leisure Properties (GLPI), Healthpeak Properties (DOC), Regency Centers (REG), Jefferies Financial Group (JEF), and Host Hotels & Resorts (HST). Howard Hughes vs. Its Competitors Taysha Gene Therapies Zillow Group Houlihan Lokey W.P. Carey American Homes 4 Rent Gaming and Leisure Properties Healthpeak Properties Regency Centers Jefferies Financial Group Host Hotels & Resorts Howard Hughes (NYSE:HHH) and Taysha Gene Therapies (NASDAQ:TSHA) are related companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and risk. Which has stronger valuation & earnings, HHH or TSHA? Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHoward Hughes$1.75B1.95$200.55M$5.2112.99Taysha Gene Therapies$8.33M67.77-$89.30M-$0.34-7.74 Is HHH or TSHA more profitable? Howard Hughes has a net margin of 14.27% compared to Taysha Gene Therapies' net margin of -1,201.08%. Howard Hughes' return on equity of 10.21% beat Taysha Gene Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Howard Hughes14.27% 10.21% 3.08% Taysha Gene Therapies -1,201.08%-104.93%-50.09% Do insiders & institutionals believe in HHH or TSHA? 93.8% of Howard Hughes shares are owned by institutional investors. Comparatively, 77.7% of Taysha Gene Therapies shares are owned by institutional investors. 33.0% of Howard Hughes shares are owned by company insiders. Comparatively, 3.8% of Taysha Gene Therapies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Does the media favor HHH or TSHA? In the previous week, Howard Hughes and Howard Hughes both had 6 articles in the media. Howard Hughes' average media sentiment score of 1.46 beat Taysha Gene Therapies' score of 0.26 indicating that Howard Hughes is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Howard Hughes 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Taysha Gene Therapies 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, HHH or TSHA? Howard Hughes has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Taysha Gene Therapies has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Do analysts recommend HHH or TSHA? Howard Hughes currently has a consensus target price of $80.33, indicating a potential upside of 18.71%. Taysha Gene Therapies has a consensus target price of $8.17, indicating a potential upside of 210.52%. Given Taysha Gene Therapies' stronger consensus rating and higher possible upside, analysts clearly believe Taysha Gene Therapies is more favorable than Howard Hughes.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Howard Hughes 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Taysha Gene Therapies 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryHoward Hughes beats Taysha Gene Therapies on 11 of the 15 factors compared between the two stocks. Get Howard Hughes News Delivered to You Automatically Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HHH vs. The Competition Export to ExcelMetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE ExchangeMarket Cap$3.41B$2.59B$11.97B$20.47BDividend YieldN/A2.88%5.67%3.71%P/E Ratio12.997.0219.7729.04Price / Sales1.953.1925.8757.15Price / Cash6.9826.8221.0722.46Price / Book1.191.032.094.43Net Income$200.55M-$106.17M$1.00B$993.74M7 Day Performance-3.00%0.40%-2.48%-3.39%1 Month Performance-2.01%7.25%-0.88%-2.10%1 Year Performance5.82%-0.52%537.05%10.09% Howard Hughes Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HHHHoward Hughes2.8345 of 5 stars$67.67-1.5%$80.33+18.7%-1.1%$3.41B$1.75B12.99608News CoveragePositive NewsTSHATaysha Gene Therapies2.9332 of 5 stars$2.53-1.6%$8.17+222.8%+21.8%$551.68M$8.33M-7.44180News CoverageShort Interest ↑ZGZillow Group3.5641 of 5 stars$74.70+0.4%$82.45+10.4%+73.9%$17.96B$2.24B-219.716,856News CoverageUpcoming EarningsShort Interest ↑HLIHoulihan Lokey4.5557 of 5 stars$194.49-0.9%$206.40+6.1%+28.8%$13.69B$2.39B33.421,100Earnings ReportDividend AnnouncementAnalyst DowngradeAnalyst RevisionWPCW.P. Carey3.3269 of 5 stars$61.85+0.3%$104.22+68.5%+13.3%$13.51B$1.58B13.04190Trending NewsEarnings ReportAnalyst ForecastShort Interest ↑AMHAmerican Homes 4 Rent4.832 of 5 stars$36.12-0.1%$40.90+13.2%-4.6%$13.38B$1.73B33.441,730Trending NewsEarnings ReportGap UpGLPIGaming and Leisure Properties4.7325 of 5 stars$46.63-2.2%$53.30+14.3%-6.0%$13.11B$1.53B16.5920DOCHealthpeak Properties4.7951 of 5 stars$18.38+0.3%$23.27+26.6%-22.9%$12.73B$2.70B45.94200News CoverageAnalyst DowngradeREGRegency Centers4.3628 of 5 stars$69.76-0.2%$77.54+11.2%+2.8%$12.68B$1.45B32.91440Earnings ReportAnalyst ForecastJEFJefferies Financial Group4.4337 of 5 stars$55.73-0.9%$66.00+18.4%-0.9%$11.60B$7.03B21.037,822Trending NewsHSTHost Hotels & Resorts4.2944 of 5 stars$16.08-0.4%$17.96+11.7%-7.3%$11.20B$5.68B16.75160Trending NewsEarnings ReportAnalyst Forecast Related Companies and Tools Related Companies Taysha Gene Therapies Competitors Zillow Group Competitors Houlihan Lokey Competitors W.P. Carey Competitors American Homes 4 Rent Competitors Gaming and Leisure Properties Competitors Healthpeak Properties Competitors Regency Centers Competitors Jefferies Financial Group Competitors Host Hotels & Resorts Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HHH) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredStrange twist to Bitcoin’s rallyThe #1 crypto to buy today Better than Bitcoin? (top crypto for less than $1) Over the past 15 years, B...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Howard Hughes Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Howard Hughes With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
